|
Clinical Director and CEO, S. Edward
Bradford, N.D., P.A.
 S. Edward Bradford is the Clinical
Director for the Immune Recovery Centers of America as well as their
Atlanta clinic's Clinical and Managing Director. He received his
Physician Assistant (PA) education at the University of Utah College of
Medicine, Physician Assistant Program, Salt Lake City, Utah. He
completed his internship in Las Vegas, Nevada and has practiced as a
civilian Physician Assistant for more than 24 years. Mr. Bradford
completed 22 ½ years of military service. Prior to his retirement from
the armed forces, he served as a Senior Instructor at the United States
Air Force School of Aerospace Medicine and as a Medical Air Crew Member
with the Air Force Aero-Medical Evacuation System.
Mr. Bradford was the CEO of three
out-patient primary care health facilities, which provided extensive
care to indigent and gray area patients. Mr. Bradford is the recipient
of the Howard County Maryland’s equivalent to the 1000 Points of Light
Award for his outstanding contributions to community health care. He is
certified by the National Commission on Certification of Physician
Assistants (NCCPA) and is a member of the American Academy of Physician
Assistants and the Georgia Association of Physician Assistants.
Director of Research, C. Richard Kinsolving, Ph.D.
 Dr. Kinsolving is a pharmaceutical
scientist as well as an executive. He was responsible for the
development and registration approval of 10 new drug entities (NDAs) and
four new formulations (ANDAs). He is the developer of the concept for
non-sedating antihistamines and the designer of the first such drug,
Seldane® (terfenadine), which reached $ 2+ billion in annual sales. He
also is listed as the inventor on 17 issued patents in the
pharmaceutical area.Dr. Kinsolving also was a member of the research
team (Post et. Al.) which discovered and named the Na+ / K+ transport
ATPase enzyme , an important component of cell and nerve electrical
transmission.
His writings have been published in more
than 45 peer-reviewed journal articles; a list of Dr. Kinsolving's
publications and patents may be found on this
link. During the last few
years, Dr. Kinsolving has dedicated himself to researching immunology in
general, and the clinical application of immunology to cancer and other
disease therapy, as the autoimmune diseases - rheumatoid arthritis and
lupus. He is currently involved with research combining IAT modified
conventional chemotherapy with immunotherapy and the combined use of
transfer factor and vaccines. Much of this work has been in
collaboration with Dr. Raymundo Diaz and Dra. Christina Rodriguez.
Dr. Kinsolving keeps the staff updated
as to how we can employ new developments and technology in our
treatments. He lectures the staff and holds Q & A sessions with the
patients. He is also assembling a group of consultants to work with IRC
in the emerging areas of Intensity Modulated Radiotherapy and Intra
Arterial Therapy. Both of these innovations offer promise in refining
the use of radiotherapy and chemotherapy respectively. This is of
particular importance because these techniques can be used with
immunotherapy if properly sequenced. The goal is to find ways to
integrate new discoveries in conventional medicine with the clinic's
work - integrative medicine.
Research and medicine are almost
synonymous. We are bombarded daily by the media with new research,
giving the promise of dramatic cures (usually years away). This is the
popular press. The real reports are found in the scientific press and
are technical, dull, and generally presented as steps rather than a
totally new therapy. New drugs reported are usually only a slight
improvement in the current catalogue (they may be financially promising,
however). IRC believes that we need to stay abreast of those new reports
that may offer a positive impact on our therapeutic protocols, which we
continually strive to improve. These reports may not reach the popular
press. They involve studies on different ways to use existing agents,
synergies seen with conventional drugs and immune agents - in short,
ways to make our therapies more effective.
Slava Pashkevich, M.D., Ph.D., MMS
 Dr. Slava Pashkevich graduated from the
Odessa Medical University in the Ukraine in 1973 with an M.D. degree in
Pediatric Neurology. He practiced at the Regional Children's Hospital
for two years and then joined the staff of The Odessa Research
Rehabilitation Institute, one of the country's premier research
facilities. In 1982 Dr. Pashkevich earned his Ph.D.
in neuro-endocrinology focusing on the treatment of obesity in children
and adolescents. Iin 1998 he earned a second Ph.D. in holistic science
and alternative medicine from LaSalle University in Lousiana. Following
his move to the United States in 1990 he worked in the Neuro-Diagnostic
Department at the Jewish Hospital as well as in the Department of
Anesthesiology at the University of Louisville. In 1999 he received a
diploma as a Fellow of the American Board of Acupuncture and was
certified in Neuro-Diagnostic and Neuro-Feedback fields.
Dr. Pashkevich completed his CEC in
Biological and Functional Medicine in 2000 in Fox Hollow, KY, and in
Schiltach, Germany. Subsequently, he established the Institute for
Integrative Medicine in Louisville, KY, where he realized his dream of
integrating traditional and non-traditional medicine. In 2001 he moved
to Atlanta and worked at the Emmanuel Center for Health, which later
became the HEALTHYSELF Center for Health. And in 2004 he joined the
Immune Recovery Foundation. Dr. Pashkevich brings along his
extraordinary commitment to healing and his extensive expertise in
acupuncture, homeopathy, herbal medicine, bio-feedback and mind-body
medicine. For a more detailed look at his work and his publications,
please click
here.
Ma. Cristina Rodriguez Padilla, Ph.D.
 Doctor Cristina
Rodriguez Padilla is the Head of the Department of Microbiology and
Immunology, and Head of the Laboratory of Virology and Immunology at the
University of Autonoma de Nuevo Leon (UANL). Dr. Rodriguez received her
doctorate at the National Polytechnic Institute in Mexico City, Mexico.
She is the Coordinator of the Master Program specializing in Immunology
of the school of Biological Sciences for the University Autonoma de
Nuevo Leon in Monterrey, Mexico. Dr. Rodriguez has been a member of the
Admissions Committee of the Masters Program specializing in Microbiology
and Immunology.
Dr. Rodriguez has been
internationally recognized for her scientific work within the
University, particularly for her research in the development of T
Lymphocytes and immuno-suppressive Cytokines. She is recognized
internationally as one of the leading experts on Transfer Factor. Her
laboratory produces Transfer Factor for worldwide use both
therapeutically and for research. Additionally, she has conducted
research in the Medical School Department of Surgery, San Antonio Health
Science Center at the University Of Texas and the Harvard School of
Public Health, Department of Cancer Biology for Safety in Laboratories
Level 2 and 3.
Dr. Rodriguez
holds one international patent, five national patents and has four
national patents pending. She routinely presents scientific papers on
her research in immunology and cancer at major scientific meetings and
has an extensive list of publications.
Director of Nurses,
Colleen Bradford, RN
 Following receipt of her Registered
Nursing (RN) license in 1989, Colleen S. Bradford joined the Oncology
Team of the University of Maryland's Medical Center at Baltimore, where
she had her introduction to the care and treatment of patients with
cancer and chronic illnesses of the immune system.
Ms. Bradford's 14 years of nursing experience also include home health,
staff school nursing, correctional medicine, as well as adolescent and
adult psychiatric care. She has served as charge nurse in various nursing disciplines and as
the Acting Director of Nursing for nine months at the Devereux Center of
Georgia.
Clinical Coordinator and Quality
Assurance, Lesley Harof, RN
 Ms. Lesley Harof is a
Registered Nurse educated at New York University-Bellevue School of
Nursing in New York City, New York. She has 13 years of Urological/Gyn/Oncology
nursing experience with acute and chronic clinical roles with Emory
University Hospital. She has spent the last 14
years as an Infusion Therapist in the field of Complementary Medicine
specializing in providing individualized treatment programs for
immunologically suppressed patients.
Ms. Harof is currently
serving as Assistant Director of Nurses, Clinical Coordinator and is
responsible for and committed to the Quality Assurance of the Immune
Recovery Foundation.
|
Resources